Cited 5 times in
The outcomes and risk factors of early readmission in patients with intestinal Behcet's disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김원호 | - |
dc.contributor.author | 김태일 | - |
dc.contributor.author | 박수정 | - |
dc.contributor.author | 박예현 | - |
dc.contributor.author | 박용은 | - |
dc.contributor.author | 천재희 | - |
dc.date.accessioned | 2019-03-15T02:28:06Z | - |
dc.date.available | 2019-03-15T02:28:06Z | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 0770-3198 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/167498 | - |
dc.description.abstract | Hospital readmission rate is an integral quality of care measurement for hospitalized patients which is unknown for intestinal Behçet's disease cases. The purpose of this study was to investigate the risk factors and outcomes for patients readmitted early with intestinal Behçet's disease. We retrospectively reviewed patients with intestinal Behçet's disease who were readmitted to our hospital between 2005 and 2016. We then analyzed the risk factors and outcomes for early readmission within 3 months. Of the 204 patients who were readmitted, 103 patients (50.5%) were readmitted within 3 months and 101 (49.5%) were never readmitted or readmitted after 3 months. After multivariate analysis, hospital stay at the first admission (adjusted odds ratio [OR], 0.945; 95% confidence interval [CI], 0.908-0.982; P = 0.004), high disease activity index for intestinal Behçet's disease score (adjusted OR, 1.111; 95% CI, 1.060-1.165; P < 0.001), corticosteroid use (adjusted OR, 3.179; 95% CI, 1.135-8.910; P = 0.028), and opioid use (adjusted OR, 7.979; 95% CI, 1.084-58.755; P = 0.041) were independent factors for early readmission. We identified four independent prognostic factors for early readmission within 3 months, which might help guide appropriate management strategies for hospitalized patients with intestinal Behçet's disease. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Springer | - |
dc.relation.isPartOf | CLINICAL RHEUMATOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adrenal Cortex Hormones/therapeutic use | - |
dc.subject.MESH | Analgesics, Opioid/therapeutic use | - |
dc.subject.MESH | Behcet Syndrome/drug therapy | - |
dc.subject.MESH | Behcet Syndrome/epidemiology* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Intestinal Diseases/drug therapy | - |
dc.subject.MESH | Intestinal Diseases/epidemiology* | - |
dc.subject.MESH | Length of Stay | - |
dc.subject.MESH | Multivariate Analysis | - |
dc.subject.MESH | Patient Readmission* | - |
dc.subject.MESH | Quality of Health Care | - |
dc.subject.MESH | Republic of Korea/epidemiology | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Risk Factors | - |
dc.subject.MESH | Time Factors | - |
dc.subject.MESH | Treatment Outcome | - |
dc.title | The outcomes and risk factors of early readmission in patients with intestinal Behcet's disease | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Yong Eun Park | - |
dc.contributor.googleauthor | Jae Hee Cheon | - |
dc.contributor.googleauthor | Yehyun Park | - |
dc.contributor.googleauthor | Soo Jung Park | - |
dc.contributor.googleauthor | Tae Il Kim | - |
dc.contributor.googleauthor | Won Ho Kim | - |
dc.identifier.doi | 10.1007/s10067-017-3904-2 | - |
dc.contributor.localId | A00774 | - |
dc.contributor.localId | A01079 | - |
dc.contributor.localId | A01539 | - |
dc.contributor.localId | A01575 | - |
dc.contributor.localId | A04571 | - |
dc.contributor.localId | A04030 | - |
dc.relation.journalcode | J00612 | - |
dc.identifier.eissn | 1434-9949 | - |
dc.identifier.pmid | 29116542 | - |
dc.identifier.url | https://link.springer.com/article/10.1007%2Fs10067-017-3904-2 | - |
dc.subject.keyword | Intestinal Behçet’s disease | - |
dc.subject.keyword | Prognostic factor | - |
dc.subject.keyword | Readmission | - |
dc.contributor.alternativeName | Kim, Won Ho | - |
dc.contributor.affiliatedAuthor | 김원호 | - |
dc.contributor.affiliatedAuthor | 김태일 | - |
dc.contributor.affiliatedAuthor | 박수정 | - |
dc.contributor.affiliatedAuthor | 박예현 | - |
dc.contributor.affiliatedAuthor | 박용은 | - |
dc.contributor.affiliatedAuthor | 천재희 | - |
dc.citation.volume | 37 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 1913 | - |
dc.citation.endPage | 1920 | - |
dc.identifier.bibliographicCitation | CLINICAL RHEUMATOLOGY, Vol.37(7) : 1913-1920, 2018 | - |
dc.identifier.rimsid | 41181 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.